Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by KBC Group NV
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by KBC Group NV
from 13F filings
Historical chart of KBC Group NV investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by KBC Group NV
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $239k | 200k | 1.20 |
2024-06-30 | $223k | 200k | 1.12 |
2024-03-31 | $195k | 200k | 0.98 |
2023-09-30 | $188k | 200k | 0.94 |
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1